Fidelity Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-127,491
Closed -$1.57M 5789
2024
Q4
$1.57M Buy
127,491
+57,395
+82% +$657K ﹤0.01% 2518
2024
Q3
$798K Buy
70,096
+63,782
+1,010% +$640K ﹤0.01% 2673
2024
Q2
$45.1K Sell
6,314
-8,907
-59% -$68.1K ﹤0.01% 3666
2024
Q1
$102K Sell
15,221
-14,403
-49% -$99.1K ﹤0.01% 3280
2023
Q4
$193K Buy
29,624
+25,659
+647% +$165K ﹤0.01% 2971
2023
Q3
$37.4K Sell
3,965
-1,441,782
-100% -$17.4M ﹤0.01% 3493
2023
Q2
$20.2M Sell
1,445,747
-806,775
-36% -$13.8M ﹤0.01% 1629
2023
Q1
$42.3M Sell
2,252,522
-196,708
-8% -$3.23M ﹤0.01% 1322
2022
Q4
$33.7M Sell
2,449,230
-3,357,584
-58% -$51.4M ﹤0.01% 1413
2022
Q3
$111M Sell
5,806,814
-281,211
-5% -$5.12M 0.01% 920
2022
Q2
$92.9M Sell
6,088,025
-1,610,784
-21% -$23.8M 0.01% 998
2022
Q1
$157M Sell
7,698,809
-527,704
-6% -$10.7M 0.01% 881
2021
Q4
$240M Sell
8,226,513
-364,632
-4% -$10.4M 0.02% 732
2021
Q3
$185M Buy
8,591,145
+30,218
+0.4% +$729K 0.01% 835
2021
Q2
$220M Buy
8,560,927
+548,413
+7% +$11.7M 0.02% 783
2021
Q1
$146M Buy
8,012,514
+7,371,183
+1,149% +$122M 0.01% 923
2020
Q4
$7.4M Buy
+641,331
New +$5.86M ﹤0.01% 2069
2016
Q1
Sell
-51,800
Closed -$424K 2751
2015
Q4
$424K Sell
51,800
-14,094
-21% -$114K ﹤0.01% 2624
2015
Q3
$470K Buy
65,894
+62,410
+1,791% +$521K ﹤0.01% 2598
2015
Q2
$32K Buy
+3,484
New +$33.5K ﹤0.01% 2716

Other funds holding CDMO

Fidelity Investments's CDMO Position: Q1 2025 in Review

Fidelity Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 127,491 shares — an estimated $1.57M sold.

Fidelity Investments first reported a position in CDMO in Q2 2015 and held it in 20 quarters. The position peaked at $240M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Fidelity Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 127,491 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.57M.
  • Fidelity Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2015 and held it in 20 quarters.
  • Fidelity Investments's Avid Bioservices, Inc. Common Stock position peaked at $240M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.